Skip to main content

Wainer Andrea F's Form 4 filing

Abbott Laboratories (ABT) · filed Jan 31, 2024

Accession no.
0001415889-24-002080
Filed
Jan 31, 2024
Trade date
Jan 29, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.78M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wainer Andrea FCIK 0001778070Officer (EXECUTIVE VICE PRESIDENT)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 29, 2024Common shares without par valueMOption exerciseAcquired+25,000$44.40+$1,110,00090,027Direct
Jan 29, 2024Common shares without par valueSSaleDisposed−25,000$112.50−$2,812,50065,027Direct
Jan 29, 2024Common shares without par valueMOption exerciseAcquired+17,500$59.94+$1,048,95082,527Direct
Jan 29, 2024Common shares without par valueSSaleDisposed−17,500$112.50−$1,968,75065,027Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 29, 2024Common SharesMOption exerciseDisposed−25,000$0.00$013,271Direct
Jan 29, 2024Common SharesMOption exerciseDisposed−17,500$0.00$046,949Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)